Mercado Global de Partículas de Embolização – Tendências do Setor e Previsão para 2028

Análise de mercado e insights do mercado de partículas de embolização                                                                                                               

Espera-se que o mercado de partículas de embolização ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa o mercado para contabilizar 3.696,48 milhões de dólares até 2028 e crescerá a um CAGR de 11,32 % no período de previsão acima referido.

A embolização é um procedimento minimamente invasivo que bloqueia o fluxo sanguíneo para uma área específica do corpo, levando à contração eficiente de um aneurisma ou tumor. Este processo é também utilizado para tratar vários tipos de tumores cancerígenos, hemorragias, bem como no tratamento da hipertensão maligna causada por insuficiência renal.

O rápido aumento da prevalência do cancro na região está entre os fatores importantes que intensificam o crescimento e a procura do mercado de partículas de embolização. Além disso, a crescente utilização da técnica de embolização como tratamento para outras condições para além do cancro, como malformações vasculares e fibrose, está também a contribuir para o crescimento do mercado global durante o período previsto de 2021 a 2028. Também a enorme expansão do domínio da saúde e O crescente foco das instituições de investigação na modernização da tecnologia para novos e avançados métodos de diagnóstico e tratamento está também a aumentar o crescimento do mercado. Da mesma forma, o turismo médico próspero, o aumento do rendimento disponível e diversos benefícios, como cirurgias minimamente invasivas, que são extremamente eficazes no controlo de hemorragias, tempo de recuperação mais rápido, redução de traumas e risco mínimo de infeção estão também a elevar o crescimento do mercado no período de previsão acima referido. A introdução constante de produtos tecnicamente avançados com maior eficiência e políticas de reembolso bem estabelecidas por organizações privadas e públicas irá acelerar ainda mais a expansão do mercado de partículas de embolização e está também a oferecer oportunidades de crescimento significativas para o mercado no período de previsão de 2021 a 2028 .

However, the presence of less number of interventional neuroradiologists and interventional neuroradiology labs will curb the growth of the embolization particle market, whereas the stringent regulatory rules have the potential to challenge the growth of the embolization particle market.

This embolization particle market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on embolization particle market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Embolization Particle Market Scope and Market Size

Embolization particle market is segmented on the basis of product type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of product type, the embolization particle market is segmented into radioembolization spheres, microspheres, drug eluting beads (DEBs), PVA particles and gelfoam particles and others.
• On the basis of application, the embolization particle market is segmented into peripheral vascular disease, neurology, oncology, urology and others.
• The end user segment of embolization particle market is segmented into hospitals, clinics, ambulatory centers and others.

Embolization Particle Market Country Level Analysis

Embolization particle market is analyzed and market size insights and trends are provided by country, product type, application and end user as referenced above.

The countries covered in the embolization particle market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the embolization particle market owing to the strong economic condition, massive expansion of healthcare domain and rising focus of research institutions on modernizing technology for new and advanced diagnosis and treatment methods within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rising patient population mainly cancer in emerging economies such as India in this particular region.

The country section of the embolization particle market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Embolization particle market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for embolization particle market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the embolization particle market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Embolization Particle Market Share Analysis

Embolization particle market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to embolization particle market.

Os principais players abordados no relatório do mercado de partículas de embolização são a Sirtex Medical Pty. Ltd., Guerbet, Boston Scientific Corporation, Medtronic, Merit Medical Systems, BTG International Ltd., KAVYA PHARMA, Which Medical Device, Varian Medical Systems, Inc. , Terumo Medical Corporation, Cook e Interface BIOmaterials, entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-59609